Alkermes plc (ALKS)
NASDAQ·Healthcare·Biotechnology
$45.09
+2.20%
Mkt Cap $7.38B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (24 analysts)
$47.25
Range $43.00 – $56.00
Implied Upside
+4.8%
Consensus $47.25 vs current $45.09
NASDAQ·Healthcare·Biotechnology
$45.09
+2.20%
Mkt Cap $7.38B
Buy
8
Hold
2
Sell
0
Price Target (24 analysts)
$47.25
Range $43.00 – $56.00
+4.8%
Consensus $47.25 vs current $45.09